Seven Eight Capital, LP Merck & Co., Inc. Transaction History
Seven Eight Capital, LP
- $1.05 Billion
- Q3 2024
A detailed history of Seven Eight Capital, LP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Seven Eight Capital, LP holds 38,198 shares of MRK stock, worth $3.75 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
38,198
Previous 17,692
115.91%
Holding current value
$3.75 Million
Previous $2.19 Million
98.04%
% of portfolio
0.41%
Previous 0.24%
Shares
20 transactions
Others Institutions Holding MRK
# of Institutions
3,827Shares Held
1.87BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.5 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.3 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.7 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.43 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.8 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $248B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...